| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/13/2009 | WO2009097970A1 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | WO2009070684A3 Hemostatic material |
| 08/13/2009 | WO2009027056A3 Antioxidant and paramagnetic heparin-nitroxide derivatives |
| 08/13/2009 | WO2008145281A3 Formulations containing triazinones and iron |
| 08/13/2009 | WO2008129396A3 Progesterone antagonist and selective progesterone modulator in the treatment of uterine bleeding |
| 08/13/2009 | WO2008071081A8 Preparation of low bleeding anticoagulant fusion protein and its use |
| 08/13/2009 | US20090204204 Drug/Drug Deliver Systems For The Prevention And Treatment Of Vascular Disease |
| 08/13/2009 | US20090203906 4-[((4-carboxybutyl){2-[2-({4-[2-(4-hydroxyphenyl)ethyl]benzyl}oxy)phenyl]-ethyl}amino)methyl]benzoic acid, which stimulate soluble guanylate cyclase via a novel mechanism of action, used for the treatment of cardiovascular disorders and fibrotic disorders |
| 08/13/2009 | US20090203767 Inhibition stat-1 |
| 08/13/2009 | US20090203729 Process for Producing High-Purity Prasugrel and Acid Addition Salt Thereof |
| 08/13/2009 | US20090203692 Novel chemical compounds |
| 08/13/2009 | US20090203633 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 08/13/2009 | US20090203613 Systems and methods for preparing autologous fibrin glue |
| 08/13/2009 | US20090202607 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 08/13/2009 | US20090202538 F11 receptor (f11r) antagonists as therapeutic agents |
| 08/13/2009 | US20090202493 Mir-150 for the treatment of blood disorders |
| 08/13/2009 | DE102008007440A1 Aminosäurederivate als Arzneistoffe Amino acid derivatives as drugs |
| 08/13/2009 | DE102008007381A1 Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten Amidines and guanidines and their derivatives for the treatment of diseases |
| 08/13/2009 | CA2713554A1 Imidazopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | CA2713551A1 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments |
| 08/13/2009 | CA2713550A1 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 08/12/2009 | EP2087891A2 Pharmaceutical compositions for treating lymphoma |
| 08/12/2009 | EP2086962A1 (r) -5-methyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylic acid 1- [( 4 -chlorophenyl) amide 5-{ [2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phenyl]amide) as a factor xa inhibitor |
| 08/12/2009 | EP1913155A4 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 08/12/2009 | EP1804780A4 Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| 08/12/2009 | EP1675579B1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 08/12/2009 | EP1427415B1 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 08/12/2009 | EP1409645B1 Probiotic lactobacillus salivarius strains |
| 08/12/2009 | EP1385514B9 Spiroindene and spiroindane compounds |
| 08/12/2009 | EP1351705B1 Compositions for treatement of hemorrhaging with activated factor viia in combination with fibrinogen |
| 08/12/2009 | EP1274319B1 Compositions and methods for improving vascular health |
| 08/12/2009 | EP1030675B1 Treatment of hematologic disorders |
| 08/12/2009 | CN101506198A Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 08/12/2009 | CN101506194A New pyridine analogues |
| 08/12/2009 | CN101506193A New pyridine analogues |
| 08/12/2009 | CN101505766A Preventive remedial therapeutic agent for phosphorus impairment, oral agent for adsorbing phosphate ion contained in food, beverage and chemical, and process for producing them |
| 08/12/2009 | CN101503726A Factor VII or VIIa-like molecules |
| 08/12/2009 | CN101503355A Synthetic refinement of triflusal |
| 08/12/2009 | CN101502634A Chinese medicinal composition for treating uterine blood flow and preparation method thereof |
| 08/12/2009 | CN101502608A Chinese paris rhizome total sapogenin oral medication preparation as well as preparation method and application thereof |
| 08/12/2009 | CN101502585A Chinese red pepper plant extract as well as preparation method and application thereof |
| 08/12/2009 | CN101502556A Cardiac and cerebral vascular disease treating medicine composition |
| 08/12/2009 | CN101502548A Method for processing cooked notoginseng |
| 08/12/2009 | CN101502539A Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation |
| 08/12/2009 | CN101502536A Cedar total flavone as well as preparation method and medical use |
| 08/12/2009 | CN101502533A Novel hydrocarbonate dialysis powder |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100525830C Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod |
| 08/12/2009 | CN100525825C 'Naoxinan' tablet in use for cardiovascular disease, cerebrovascular disease and preparation method |
| 08/12/2009 | CN100525777C Depolymerization glycosaminoglycan extracted from sea cucumber composition and its preparation method and application |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572827 Administering bergapten; modulate the expression of genes for gamma-globin in the human cell line K562; genetic blood disorders |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/11/2009 | US7572619 Using immortalized trangenic cell to express antihemophilic factor and blood coagulation factor IX for treatment of blood disorders |
| 08/11/2009 | US7572591 Thrombotic thrombocytopenic purpura (TTP); epitope recognized by an antibody (anti-ADAMTS-13 antibody) against a cleaving protease ( ADAMTS-13) specific to von Willebrand factor |
| 08/11/2009 | US7572469 Therapeutic lotion for dermatitis |
| 08/11/2009 | US7572442 Selected antibody compositions for binding to aminophospholipids |
| 08/11/2009 | US7572437 Long acting human interferon analogs |
| 08/11/2009 | CA2448825C Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/11/2009 | CA2408535C Compositions comprising dendrimer complexes |
| 08/11/2009 | CA2395846C Diazepan derivatives or salts thereof |
| 08/06/2009 | WO2009097120A1 Methods using immunomodulatory compounds for modulating level of cd59 |
| 08/06/2009 | WO2009096503A1 Benzyl phenyl glucopyranoside derivative |
| 08/06/2009 | WO2009095503A2 Amino acid derivatives used as pharmaceutical substances |
| 08/06/2009 | WO2009095499A1 Use of amidoxime carboxylic acid esters and n-hydroxyguanidine carboxylic acid esters for producing prodrugs |
| 08/06/2009 | WO2009095163A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/06/2009 | WO2009094718A1 Methods of treating thromboembolic disorders |
| 08/06/2009 | WO2009053999A3 Sulfoximine derivatives as factor xa inhibitors |
| 08/06/2009 | US20090197813 Methods for treating FSH related conditions with GnRH antagonists |
| 08/06/2009 | US20090196928 Biocompatible hydrogel compositions |
| 08/06/2009 | DE102008007400A1 Substituierte Furane und ihre Verwendung Substituted furans and their use |
| 08/06/2009 | CA2713784A1 Use of amidoxime carboxylic acid esters and n-hydroxyguanidine carboxylic acid esters for producing prodrugs |
| 08/06/2009 | CA2713780A1 Amino acid derivatives used as pharmaceutical substances |
| 08/06/2009 | CA2712854A1 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 08/06/2009 | CA2712724A1 Use of lenalidomide or pomalidomide for treating a disease associated with cd59 deficiency |
| 08/05/2009 | EP2085780A2 Methods and products related to low molecular weight heparin |
| 08/05/2009 | EP2085471A2 Modified factor VIIA polypeptides |
| 08/05/2009 | EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade |
| 08/05/2009 | EP2085093A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 08/05/2009 | EP2085088A1 Adhesive preparation |
| 08/05/2009 | EP2084154A1 Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders |
| 08/05/2009 | EP2084151A1 Substituted dihydropyrazolones for treating cardiovascular and haematological diseases |
| 08/05/2009 | EP2083848A1 Method of treatment and prophylaxis |
| 08/05/2009 | EP1663280B1 Compositions based on T-4 immune stimulating factor ("TISF") for the treatment of red blood cells, granulocytes and platelets deficiency |
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1445253B1 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
| 08/05/2009 | EP1442115B1 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 08/05/2009 | EP1383731B1 Biaryl compounds as serine protease inhibitors |
| 08/05/2009 | EP1286703B1 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 08/05/2009 | CN101501056A Aptamers that bind thrombin with high affinity |
| 08/05/2009 | CN101501049A Aminophosphoric acid ester derivative and S1P receptor modulator containing the same as active ingredient |
| 08/05/2009 | CN101500993A 2-aminocarbonylphenylamino-2-phenilacetamides as factor VIIa inhibitors useful as anticoagulants |
| 08/05/2009 | CN101500609A Hematopoietic stem cell proliferation promoter |
| 08/05/2009 | CN101500569A HIF hydroxylase inhibitors for treatment of anemia of cancer |
| 08/05/2009 | CN101497887A Efficient and stable expression, purification and use of recombinant snake poison metal protease Jerdonitin |
| 08/05/2009 | CN101497660A Strongylus duodenalis anticoagulant peptide, as well as preparation and use thereof |
| 08/05/2009 | CN101497651A Compound with thrombus dissolving activity, as well as preparation and use thereof |
| 08/05/2009 | CN101497570A Salvianolic acid A amino-acid salt, preparation, powder injection composition and use |
| 08/05/2009 | CN101497557A Method for extracting purified solanesol from potato leaf |